Evaluation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease
NCT ID: NCT03914079
Last Updated: 2021-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
2000 participants
OBSERVATIONAL
2019-04-05
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intraprocedural Determination of Myocardial Vitality Using 2 Different Imaging Methods
NCT01934699
Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
NCT00692991
Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease 2
NCT03481712
Cardiovascular Imaging Registry of Canada
NCT04367220
A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease
NCT04464655
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Suspected or known CAD;
3. Able and willing to comply with the study procedures;
4. Referred to ICA or CCTA for CAD characterization;
5. Willingness and ability to sign the Informed Consent Form.
Exclusion Criteria
2. Age less than 19 years;
3. Pregnancy;
4. Skin injury/diseases/lesions that would preclude safe application of the CAD-det device.
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ottawa Heart Institute Research Corporation
OTHER
Horizon Health Network
OTHER
University of Calgary
OTHER
Hamilton Health Sciences Corporation
OTHER
AusculSciences Canada Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin Chow, MD, FRCP(C)
Role: PRINCIPAL_INVESTIGATOR
University of Ottawa Heart Institute (UOHI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foothills Medical Centre (University of Calgary)
Calgary, Alberta, Canada
Horizon Health Network, Saint John Regional Hospital
Saint John, New Brunswick, Canada
University of Ottawa Heart Institute
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Makaryus AN, Makaryus JN, Figgatt A, Mulholland D, Kushner H, Semmlow JL, Mieres J, Taylor AJ. Utility of an advanced digital electronic stethoscope in the diagnosis of coronary artery disease compared with coronary computed tomographic angiography. Am J Cardiol. 2013 Mar 15;111(6):786-92. doi: 10.1016/j.amjcard.2012.11.039. Epub 2013 Jan 1.
Related Links
Access external resources that provide additional context or updates about the study.
Study Sponsor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAD-det-Research-Study
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.